Cargando…

Vitamin D deficiency among patients with pulmonary hypertension

BACKGROUND: There is little information about vitamin D (Vit D) deficiency in patients with pulmonary hypertension (PH). The objective of this study was: 1) compare Vit D levels between patients with PH, left ventricular failure (LVF) and healthy subjects (HS); 2) correlate, in patients with PH, Vit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atamañuk, Andrés N., Litewka, Diego F., Baratta, Sergio J., Seropian, Ignacio M., Perez Prados, Graciela, Payaslian, Miguel O., Ortiz Fragola, Juan P., Escribano Subias, Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925472/ https://www.ncbi.nlm.nih.gov/pubmed/31864342 http://dx.doi.org/10.1186/s12890-019-1011-7

Ejemplares similares

Total, Bioavailable, and Free Vitamin D Levels and Their Prognostic Value in Pulmonary Arterial Hypertension
por: Callejo, Maria, et al.
Publicado: (2020)

Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension
por: Martin de Miguel, Irene, et al.
Publicado: (2023)

Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
por: Escribano-Subias, Pilar, et al.
Publicado: (2019)

Characterization of rare ABCC8 variants identified in Spanish pulmonary arterial hypertension patients
por: Lago-Docampo, Mauro, et al.
Publicado: (2020)

COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
por: Belge, Catharina, et al.
Publicado: (2020)

Clinical course of COVID-19 in pulmonary arterial hypertension patients
por: Nuche, Jorge, et al.
Publicado: (2020)

Novel Genetic and Molecular Pathways in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease
por: Hernandez-Gonzalez, Ignacio, et al.
Publicado: (2021)

Characterization and regulation of wild‐type and mutant TASK‐1 two pore domain potassium channels indicated in pulmonary arterial hypertension
por: Cunningham, Kevin P., et al.
Publicado: (2018)

Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: results from the PRACMA study
por: Escribano-Subias, Pilar, et al.
Publicado: (2020)

COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?
por: Segura de la Cal, Teresa, et al.
Publicado: (2021)

Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension
por: Nuche, Jorge, et al.
Publicado: (2020)

Expanding the Evidence of a Semi-Dominant Inheritance in GDF2 Associated with Pulmonary Arterial Hypertension
por: Gallego, Natalia, et al.
Publicado: (2021)

Unexpected Favourable Course of Coronavirus Disease 2019 in Chronic Thromboembolic Pulmonary Hypertension Patients
por: Segura de la Cal, Teresa, et al.
Publicado: (2020)

Description of Two New Cases of AQP1 Related Pulmonary Arterial Hypertension and Review of the Literature
por: Gallego-Zazo, Natalia, et al.
Publicado: (2022)

Effectiveness and Safety of Balloon Pulmonary Angioplasty for the Treatment of Patients with Persistent Pulmonary Hypertension after Pulmonary Endarterectomy
por: Maneiro Melon, Nicolas M., et al.
Publicado: (2023)

Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry
por: Garcia, Agustin R., et al.
Publicado: (2023)

Customized Massive Parallel Sequencing Panel for Diagnosis of Pulmonary Arterial Hypertension
por: Castaño, Jair Antonio Tenorio, et al.
Publicado: (2020)

Benefits from the correction of vitamin D deficiency in patients with pulmonary hypertension
por: Mirdamadi, Ahmad, et al.
Publicado: (2016)

The impact of COVID‐19 pandemic on pulmonary hypertension: What have we learned?
por: Hinojosa, Williams, et al.
Publicado: (2022)

Restoration of Vitamin D Levels Improves Endothelial Function and Increases TASK-Like K(+) Currents in Pulmonary Arterial Hypertension Associated with Vitamin D Deficiency
por: Callejo, Maria, et al.
Publicado: (2021)

Clinical heterogeneity of Pulmonary Arterial Hypertension associated with variants in TBX4
por: Hernandez-Gonzalez, Ignacio, et al.
Publicado: (2020)

Effects of an 8-month exercise intervention on physical capacity, NT-proBNP, physical activity levels and quality of life data in patients with pulmonary arterial hypertension by NYHA class
por: Santos-Lozano, Alejandro, et al.
Publicado: (2017)

Sex Differences in Chronic Thromboembolic Pulmonary Hypertension. Treatment Options over Time in a National Referral Center
por: Cruz-Utrilla, Alejandro, et al.
Publicado: (2021)

Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta
por: Nuche, Jorge, et al.
Publicado: (2020)

The role of cardiopulmonary exercise testing in identifying and monitoring pulmonary veno-oclusive disease: a case report
por: Segura de la Cal, Teresa, et al.
Publicado: (2022)

Right Ventricular Dysfunction following Acute Myocardial Infarction in the Absence of Pulmonary Hypertension in the Mouse
por: Toldo, Stefano, et al.
Publicado: (2011)

Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
por: Humbert, Marc, et al.
Publicado: (2023)

Feasibility of a Noninvasive Operability Assessment in Chronic Thromboembolic Pulmonary Hypertension under Real-World Practice
por: Rodriguez Chaverri, Adriana, et al.
Publicado: (2020)

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function
por: Lang, Irene M, et al.
Publicado: (2023)

Does Vitamin D Deficiency Lead to Hypertension?
por: Mehta, Varshil, et al.
Publicado: (2017)

Evaluation of a digital health system (PAHcare™) for routine care of patients with pulmonary arterial hypertension: The CBS-PAH study protocol
por: Pérez Peñate, Gregorio, et al.
Publicado: (2022)

Selective Segmental Pulmonary Angiography: Anatomical, Technical and Safety Aspects of a Must-Learn Technique in Times of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension
por: Velázquez, Maite, et al.
Publicado: (2021)

The Importance of Symptomatic or Asymptomatic Transcatheter Heart Valve Thrombosis
por: Seropian, Ignacio M.
Publicado: (2021)

PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic
por: Godinas, Laurent, et al.
Publicado: (2021)

Lung and heart-lung transplantation in pulmonary arterial hypertension
por: López-Meseguer, Manuel, et al.
Publicado: (2017)

An open‐label, dose‐escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension
por: Simon, Marc A., et al.
Publicado: (2022)

Giant pulmonary artery aneurysm in a patient with vasoreactive pulmonary hypertension: a case report
por: Araújo, Inês, et al.
Publicado: (2011)

Correction: Lung and heart-lung transplantation in pulmonary arterial hypertension
por: López-Meseguer, Manuel, et al.
Publicado: (2018)

The role of vitamin D in chronic obstructive pulmonary disease with pulmonary hypertension
por: Li, Mengxi
Publicado: (2023)

Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rq7pgplin25i6b7huaeg7el4ec